World Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.21M Buy
5,729
+331
+6% +$122K 0.22% 92
2021
Q2
$1.27M Buy
5,398
+455
+9% +$81.3K 0.12% 184
2021
Q1
$884K Sell
4,943
-347
-7% -$50.3K 0.08% 253
2020
Q4
$553K Buy
5,290
+154
+3% +$15.6K 0.05% 358
2020
Q3
$363K Buy
5,136
+295
+6% +$20.6K 0.04% 474
2020
Q2
$311K Buy
+4,841
New +$265K 0.03% 518

Other funds holding MRNA

World Asset Management's MRNA Position: Q3 2021 in Review

World Asset Management increased its Moderna (MRNA) stake by 6.1% in Q3 2021, buying an estimated $122K and bringing the position to 5,729 shares worth $2.21M. The position accounts for 0.22% of the portfolio, ranked #92.

World Asset Management first reported a position in MRNA in Q2 2020 and has held it in 6 quarters since. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • World Asset Management held 5,729 shares of Moderna worth $2.21M as of Q3 2021.
  • World Asset Management bought 331 Moderna shares in Q3 2021, an estimated $122K.
  • Moderna made up 0.22% of World Asset Management's portfolio in Q3 2021, its #92 holding.
  • World Asset Management first reported a position in Moderna in Q2 2020 and has held it in 6 quarters since.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.